This combination was motivated by previous reports that ATRT has aberrant H3K27ac downstream of SMARCB1 inactivation, that is met with elevated DNA methylation over these sites, and that hypomethylation and hyperacetylation can elicit innate immune signaling in other tumor types [5, 15, 31]. Here, SMARCB1 is linked to neoplasm.